Published in J Gastrointest Cancer on June 01, 2013
Dietary inflammatory index and risk of pancreatic cancer in an Italian case-control study. Br J Nutr (2014) 1.12
Risk factors and therapeutic targets in pancreatic cancer. Front Oncol (2013) 0.88
Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study. Int J Cancer (2013) 0.86
Dietary Patterns and Pancreatic Cancer Risk: A Meta-Analysis. Nutrients (2017) 0.86
Current status and progress of pancreatic cancer in China. World J Gastroenterol (2015) 0.83
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer. Mar Drugs (2015) 0.82
Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway. Evid Based Complement Alternat Med (2013) 0.81
The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome. Pancreas (2015) 0.78
Surveillance for neoplasia in the pancreas. Best Pract Res Clin Gastroenterol (2016) 0.78
Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators. Aging Dis (2013) 0.78
Vitamin C Intake and Pancreatic Cancer Risk: A Meta-Analysis of Published Case-Control and Cohort Studies. PLoS One (2016) 0.77
Association between vitamin C intake and the risk of pancreatic cancer: a meta-analysis of observational studies. Sci Rep (2015) 0.77
Association between vitamin A, retinol and carotenoid intake and pancreatic cancer risk: Evidence from epidemiologic studies. Sci Rep (2016) 0.75
The association between dietary zinc intake and risk of pancreatic cancer: A meta-analysis. Biosci Rep (2017) 0.75
Association between selenium intake and the risk of pancreatic cancer: a meta-analysis of observational studies. Biosci Rep (2016) 0.75
Magnesium intake and incidence of pancreatic cancer: the VITamins and Lifestyle study. Br J Cancer (2015) 0.75
The association between dietary vitamin A intake and pancreatic cancer risk: a meta-analysis of 11 studies. Biosci Rep (2016) 0.75
Mechanistic insight into beta-carotene-mediated protection against ulcerative colitis-associated local and systemic damage in mice. Eur J Nutr (2014) 0.75
Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34
Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol (2003) 6.78
Abnormal glucose metabolism and pancreatic cancer mortality. JAMA (2000) 4.01
Prospective study of hyperglycemia and cancer risk. Diabetes Care (2007) 2.89
Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol (2002) 2.83
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA (2005) 2.71
Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care (2004) 2.24
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res (2004) 1.84
Nutritional factors and risk of pancreatic cancer: a population-based case-control study based on direct interview in Japan. J Gastroenterol (2005) 1.78
Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res (1996) 1.69
Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med (2007) 1.65
Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev (2005) 1.59
Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab (2005) 1.54
Detecting early pancreatic cancer: problems and prospects. Semin Oncol (2007) 1.54
Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control (2009) 1.53
Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care (2003) 1.50
Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.48
Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women. Cancer Epidemiol Biomarkers Prev (2007) 1.44
Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control (2008) 1.35
Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr (2007) 1.34
Diet and cancer prevention. Oncogene (2004) 1.33
Dietary patterns and risk of pancreatic cancer. Int J Cancer (2005) 1.28
Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst (1999) 1.27
Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic Res (2004) 1.25
Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol (2003) 1.21
Nutritional factors and pancreatic cancer in the francophone community in Montréal, Canada. Int J Cancer (1991) 1.20
Nutrients and pancreatic cancer: a population-based case-control study. Cancer Causes Control (1991) 1.18
A collaborative case-control study of nutrient intake and pancreatic cancer within the search programme. Int J Cancer (1992) 1.17
Fruit and vegetable consumption is inversely associated with having pancreatic cancer. Cancer Causes Control (2011) 1.10
Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas (2003) 1.00
Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer (2008) 0.99
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab (1994) 0.95
Health and wealth. The late-20th century obesity epidemic in the U.S. Econ Hum Biol (2005) 0.94
Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol (1995) 0.93
Vitamin E intake, alpha-tocopherol status, and pancreatic cancer in a cohort of male smokers. Am J Clin Nutr (2008) 0.91
Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr (2005) 0.89
Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord (2002) 0.89
Insulin secretion as a determinant of pancreatic cancer risk. Med Hypotheses (2001) 0.89
Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur J Nutr (2007) 0.87
Effects of voluntary physical exercise on high-fat diet-promoted pancreatic carcinogenesis in the hamster model. Nutr Cancer (1996) 0.86
Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health (2007) 0.86
Relationships between different types of fruit and vegetable consumption and serum concentrations of antioxidant vitamins. Br J Nutr (2008) 0.84
Inflammation-related gene variants as risk factors for pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2011) 0.84
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
International network of cancer genome projects. Nature (2010) 20.35
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet (2011) 8.57
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet (2005) 6.86
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol (2002) 5.91
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Association of coffee drinking with total and cause-specific mortality. N Engl J Med (2012) 5.31
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA (2006) 4.87
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol (2006) 4.22
A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science (2009) 4.16
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol (2009) 4.13
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA (2005) 3.99
Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev (2010) 3.95
Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet (2011) 3.85
Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol (2006) 3.81
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology (2009) 3.50
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49
Validation of a new coma scale: The FOUR score. Ann Neurol (2005) 3.39
Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res (2004) 3.31
Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol (2007) 3.30
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet (2007) 3.28
ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov (2011) 3.27
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology (2007) 3.20
Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med (2002) 3.16
Meat consumption and risk of colorectal cancer. JAMA (2005) 3.15
Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res (2005) 3.11
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol (2004) 3.10
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst (2006) 3.08
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst (2009) 2.88
Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2005) 2.82
Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA (2003) 2.81
Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst (2013) 2.76
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg (2002) 2.68
Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology (2005) 2.60
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol (2009) 2.53
Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes (2003) 2.53
A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med (2007) 2.49
Quality control procedures for genome-wide association studies. Curr Protoc Hum Genet (2011) 2.48
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology (2004) 2.35
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology (2012) 2.33
Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer (2009) 2.32
Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics (2004) 2.31
Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer (2004) 2.25
Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res (2002) 2.23
Meat-related mutagens/carcinogens in the etiology of colorectal cancer. Environ Mol Mutagen (2004) 2.22
RNA-seq: technical variability and sampling. BMC Genomics (2011) 2.19
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med (2009) 2.19
Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J Natl Cancer Inst (2004) 2.17
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst (2008) 2.17
The metabolic syndrome and risk of incident colorectal cancer. Cancer (2006) 2.16
Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res (2005) 2.15
Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst (2008) 2.15
Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev (2013) 2.14
Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med (2008) 2.14
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation (2006) 2.11
Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev (2006) 2.04
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer (2008) 2.04
A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev (2009) 2.04
The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.03
A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res (2006) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol (2008) 2.01
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum Genet (2011) 2.00